PubMed:26786498
Annnotations
Glycan-Motif
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 466-473 | https://glytoucan.org/Structures/Glycans/G70323CJ | denotes | mannose |
| T2 | 964-971 | https://glytoucan.org/Structures/Glycans/G70323CJ | denotes | mannose |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 466-473 | Glycan_Motif | denotes | mannose | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G70323CJ |
| T2 | 964-971 | Glycan_Motif | denotes | mannose | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G70323CJ |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 466-473 | https://glytoucan.org/Structures/Glycans/G70323CJ | denotes | mannose |
| T2 | 964-971 | https://glytoucan.org/Structures/Glycans/G70323CJ | denotes | mannose |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-130 | Sentence | denotes | Profiling N-Linked Oligosaccharides from IgG by High-Performance Anion-Exchange Chromatography with Pulsed Amperometric Detection. |
| TextSentencer_T2 | 131-321 | Sentence | denotes | Understanding and characterizing protein therapeutic glycosylation is important with growing evidence that glycosylation impacts biological efficacy, pharmacokinetics, and cellular toxicity. |
| TextSentencer_T3 | 322-447 | Sentence | denotes | Protein expression systems and reactor conditions can impact glycosylation, leading to potentially undesirable glycosylation. |
| TextSentencer_T4 | 448-549 | Sentence | denotes | For example, high-mannose species may be present, which are atypical of human antibody glycosylation. |
| TextSentencer_T5 | 550-645 | Sentence | denotes | Their presence in the Fc domain has been linked to increased serum clearance of IgG antibodies. |
| TextSentencer_T6 | 646-821 | Sentence | denotes | High-performance anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD) is an effective tool for determining glycans present in glycoprotein therapeutics. |
| TextSentencer_T7 | 822-895 | Sentence | denotes | We report an improved HPAE-PAD method for IgG oligosaccharide separation. |
| TextSentencer_T8 | 896-1011 | Sentence | denotes | The neutral glycans are well resolved, including separation of high-mannose species from typical human IgG glycans. |
| TextSentencer_T9 | 1012-1184 | Sentence | denotes | Oligosaccharide identification was performed by comparison to known standards in conjunction with selective exoglycosidase digestion of both standards and released glycans. |
| TextSentencer_T10 | 1185-1358 | Sentence | denotes | Retention times of known glycans were compared to the retention times of maltose, maltotriose, and maltotetraose standards to define a retention index value for each glycan. |
| TextSentencer_T11 | 1359-1494 | Sentence | denotes | These retention indices were used to aid identification of glycans from an example monoclonal antibody sample of unknown glycosylation. |
| TextSentencer_T12 | 1495-1590 | Sentence | denotes | Method ruggedness was evaluated across duplicate systems, analysts, and triplicate column lots. |
| TextSentencer_T13 | 1591-1769 | Sentence | denotes | Comparing two systems with different analysts and columns, retention time precision RSDs were between 0.63 and 4.0% while retention indices precision RSDs ranged from 0.27-0.56%. |
| TextSentencer_T14 | 1770-1877 | Sentence | denotes | The separation is orthogonal to capillary electrophoresis based separation of labeled IgG oligosaccharides. |
| T5 | 550-645 | Sentence | denotes | Their presence in the Fc domain has been linked to increased serum clearance of IgG antibodies. |
| T6 | 646-821 | Sentence | denotes | High-performance anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD) is an effective tool for determining glycans present in glycoprotein therapeutics. |
| T7 | 822-895 | Sentence | denotes | We report an improved HPAE-PAD method for IgG oligosaccharide separation. |
| T8 | 896-1011 | Sentence | denotes | The neutral glycans are well resolved, including separation of high-mannose species from typical human IgG glycans. |
| T9 | 1012-1184 | Sentence | denotes | Oligosaccharide identification was performed by comparison to known standards in conjunction with selective exoglycosidase digestion of both standards and released glycans. |
| T10 | 1185-1358 | Sentence | denotes | Retention times of known glycans were compared to the retention times of maltose, maltotriose, and maltotetraose standards to define a retention index value for each glycan. |
| T11 | 1359-1494 | Sentence | denotes | These retention indices were used to aid identification of glycans from an example monoclonal antibody sample of unknown glycosylation. |
| T12 | 1495-1590 | Sentence | denotes | Method ruggedness was evaluated across duplicate systems, analysts, and triplicate column lots. |
| T13 | 1591-1769 | Sentence | denotes | Comparing two systems with different analysts and columns, retention time precision RSDs were between 0.63 and 4.0% while retention indices precision RSDs ranged from 0.27-0.56%. |
| T14 | 1770-1877 | Sentence | denotes | The separation is orthogonal to capillary electrophoresis based separation of labeled IgG oligosaccharides. |
| T1 | 0-130 | Sentence | denotes | Profiling N-Linked Oligosaccharides from IgG by High-Performance Anion-Exchange Chromatography with Pulsed Amperometric Detection. |
| T2 | 131-321 | Sentence | denotes | Understanding and characterizing protein therapeutic glycosylation is important with growing evidence that glycosylation impacts biological efficacy, pharmacokinetics, and cellular toxicity. |
| T3 | 322-447 | Sentence | denotes | Protein expression systems and reactor conditions can impact glycosylation, leading to potentially undesirable glycosylation. |
| T4 | 448-549 | Sentence | denotes | For example, high-mannose species may be present, which are atypical of human antibody glycosylation. |
| T1 | 0-130 | Sentence | denotes | Profiling N-Linked Oligosaccharides from IgG by High-Performance Anion-Exchange Chromatography with Pulsed Amperometric Detection. |
| T2 | 131-321 | Sentence | denotes | Understanding and characterizing protein therapeutic glycosylation is important with growing evidence that glycosylation impacts biological efficacy, pharmacokinetics, and cellular toxicity. |
| T3 | 322-447 | Sentence | denotes | Protein expression systems and reactor conditions can impact glycosylation, leading to potentially undesirable glycosylation. |
| T4 | 448-549 | Sentence | denotes | For example, high-mannose species may be present, which are atypical of human antibody glycosylation. |
| T5 | 550-645 | Sentence | denotes | Their presence in the Fc domain has been linked to increased serum clearance of IgG antibodies. |
| T6 | 646-821 | Sentence | denotes | High-performance anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD) is an effective tool for determining glycans present in glycoprotein therapeutics. |
| T7 | 822-895 | Sentence | denotes | We report an improved HPAE-PAD method for IgG oligosaccharide separation. |
| T8 | 896-1011 | Sentence | denotes | The neutral glycans are well resolved, including separation of high-mannose species from typical human IgG glycans. |
| T9 | 1012-1184 | Sentence | denotes | Oligosaccharide identification was performed by comparison to known standards in conjunction with selective exoglycosidase digestion of both standards and released glycans. |
| T10 | 1185-1358 | Sentence | denotes | Retention times of known glycans were compared to the retention times of maltose, maltotriose, and maltotetraose standards to define a retention index value for each glycan. |
| T11 | 1359-1494 | Sentence | denotes | These retention indices were used to aid identification of glycans from an example monoclonal antibody sample of unknown glycosylation. |
| T12 | 1495-1590 | Sentence | denotes | Method ruggedness was evaluated across duplicate systems, analysts, and triplicate column lots. |
| T13 | 1591-1769 | Sentence | denotes | Comparing two systems with different analysts and columns, retention time precision RSDs were between 0.63 and 4.0% while retention indices precision RSDs ranged from 0.27-0.56%. |
| T14 | 1770-1877 | Sentence | denotes | The separation is orthogonal to capillary electrophoresis based separation of labeled IgG oligosaccharides. |
ICD10
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1093-1104 | http://purl.bioontology.org/ontology/ICD10/H10 | denotes | conjunction |
| T2 | 1093-1104 | http://purl.bioontology.org/ontology/ICD10/H10.9 | denotes | conjunction |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T19 | 964-971 | FMAID:82801 | denotes | mannose |
| _T1 | 19-35 | FMAID:82742 | denotes | Oligosaccharides |
| _T2 | 19-35 | FMAID:196731 | denotes | Oligosaccharides |
| _T3 | 41-44 | FMAID:167179 | denotes | IgG |
| _T4 | 164-171 | FMAID:165447 | denotes | protein |
| _T5 | 164-171 | FMAID:67257 | denotes | protein |
| _T6 | 322-329 | FMAID:67257 | denotes | Protein |
| _T7 | 322-329 | FMAID:165447 | denotes | Protein |
| _T8 | 466-473 | FMAID:196796 | denotes | mannose |
| _T9 | 466-473 | FMAID:82801 | denotes | mannose |
| _T10 | 526-534 | FMAID:167180 | denotes | antibody |
| _T11 | 611-616 | FMAID:167330 | denotes | serum |
| _T12 | 630-633 | FMAID:167179 | denotes | IgG |
| _T13 | 634-644 | FMAID:167180 | denotes | antibodies |
| _T14 | 795-807 | FMAID:62925 | denotes | glycoprotein |
| _T15 | 795-807 | FMAID:167256 | denotes | glycoprotein |
| _T16 | 864-867 | FMAID:167179 | denotes | IgG |
| _T17 | 868-883 | FMAID:196731 | denotes | oligosaccharide |
| _T18 | 868-883 | FMAID:82742 | denotes | oligosaccharide |
| _T20 | 964-971 | FMAID:196796 | denotes | mannose |
| _T21 | 999-1002 | FMAID:167179 | denotes | IgG |
| _T22 | 1012-1027 | FMAID:196731 | denotes | Oligosaccharide |
| _T23 | 1012-1027 | FMAID:82742 | denotes | Oligosaccharide |
| _T24 | 1330-1335 | FMAID:214893 | denotes | index |
| _T25 | 1453-1461 | FMAID:167180 | denotes | antibody |
| _T26 | 1578-1584 | FMAID:76737 | denotes | column |
| _T27 | 1578-1584 | FMAID:183891 | denotes | column |
| _T28 | 1641-1648 | FMAID:76737 | denotes | columns |
| _T29 | 1641-1648 | FMAID:183891 | denotes | columns |
| _T30 | 1802-1811 | FMAID:63194 | denotes | capillary |
| _T31 | 1802-1811 | FMAID:167591 | denotes | capillary |
| _T32 | 1856-1859 | FMAID:167179 | denotes | IgG |
| _T33 | 1860-1876 | FMAID:82742 | denotes | oligosaccharides |
| _T34 | 1860-1876 | FMAID:196731 | denotes | oligosaccharides |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 734-737 | http://www.uniprot.org/uniprot/Q8IX18 | denotes | PAD |
| T2 | 849-852 | http://www.uniprot.org/uniprot/Q8IX18 | denotes | PAD |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1442-1452 | http://purl.bioontology.org/ontology/NCBITAXON/608684 | denotes | monoclonal |
| T2 | 1788-1798 | http://purl.bioontology.org/ontology/NCBITAXON/1271577 | denotes | orthogonal |
| T3 | 1802-1811 | http://purl.bioontology.org/ontology/NCBITAXON/241203 | denotes | capillary |
| T4 | 1802-1811 | http://purl.bioontology.org/ontology/NCBITAXON/119095 | denotes | capillary |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 71-79 | http://purl.obolibrary.org/obo/GO_0015297 | denotes | Exchange |
| T2 | 669-677 | http://purl.obolibrary.org/obo/GO_0015297 | denotes | exchange |
| T3 | 184-197 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T4 | 238-251 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T5 | 383-396 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T6 | 433-446 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T7 | 535-548 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T8 | 1480-1493 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T9 | 303-311 | http://purl.obolibrary.org/obo/GO_0007349 | denotes | cellular |
| T10 | 1135-1144 | http://purl.obolibrary.org/obo/GO_0007586 | denotes | digestion |
| T11 | 1185-1194 | http://purl.obolibrary.org/obo/GO_0051235 | denotes | Retention |
| T12 | 1239-1248 | http://purl.obolibrary.org/obo/GO_0051235 | denotes | retention |
| T13 | 1320-1329 | http://purl.obolibrary.org/obo/GO_0051235 | denotes | retention |
| T14 | 1365-1374 | http://purl.obolibrary.org/obo/GO_0051235 | denotes | retention |
| T15 | 1650-1659 | http://purl.obolibrary.org/obo/GO_0051235 | denotes | retention |
| T16 | 1713-1722 | http://purl.obolibrary.org/obo/GO_0051235 | denotes | retention |
GO-MF
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 526-534 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibody |
| T2 | 634-644 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
GO-CC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 630-644 | http://purl.obolibrary.org/obo/GO_0071736 | denotes | IgG antibodies |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 611-616 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
| T2 | 734-737 | http://purl.obolibrary.org/obo/UBERON_2001977 | denotes | PAD |
| T3 | 849-852 | http://purl.obolibrary.org/obo/UBERON_2001977 | denotes | PAD |
| T4 | 1802-1811 | http://purl.obolibrary.org/obo/UBERON_0001982 | denotes | capillary |
GlycoBiology-Motifs
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 461-473 | http://rdf.glycoinfo.org/glycan/G00028MO | denotes | high-mannose |
| T2 | 959-971 | http://rdf.glycoinfo.org/glycan/G00028MO | denotes | high-mannose |
GlycoBiology-Epitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-GlycoEpitope-B_T1 | 1848-1855 | id | denotes | labeled |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 611-616 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
| PD-UBERON-AE-B_T2 | 734-737 | http://purl.obolibrary.org/obo/UBERON_2001977 | denotes | PAD |
| PD-UBERON-AE-B_T3 | 849-852 | http://purl.obolibrary.org/obo/UBERON_2001977 | denotes | PAD |
| PD-UBERON-AE-B_T4 | 1802-1811 | http://purl.obolibrary.org/obo/UBERON_0001982 | denotes | capillary |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 1258-1265 | Glycan | denotes | maltose | https://api.glycosmos.org/wurcs2image/latest/png/binary/G44653LT |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 1675-1679 | Disease | denotes | RSDs | http://purl.obolibrary.org/obo/MONDO_0011441 |
| T2 | 1741-1745 | Disease | denotes | RSDs | http://purl.obolibrary.org/obo/MONDO_0011441 |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 1258-1265 | Glycan | denotes | maltose | https://api.glycosmos.org/wurcs2image/latest/png/binary/G44653LT |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 1802-1811 | Body_part | denotes | capillary | http://purl.obolibrary.org/obo/UBERON_0001982 |
GlyCosmos15-Taxon
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 520-525 | Organism | denotes | human | 9606 |
| T2 | 993-998 | Organism | denotes | human | 9606 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-130 | Sentence | denotes | Profiling N-Linked Oligosaccharides from IgG by High-Performance Anion-Exchange Chromatography with Pulsed Amperometric Detection. |
| T2 | 131-321 | Sentence | denotes | Understanding and characterizing protein therapeutic glycosylation is important with growing evidence that glycosylation impacts biological efficacy, pharmacokinetics, and cellular toxicity. |
| T3 | 322-447 | Sentence | denotes | Protein expression systems and reactor conditions can impact glycosylation, leading to potentially undesirable glycosylation. |
| T4 | 448-549 | Sentence | denotes | For example, high-mannose species may be present, which are atypical of human antibody glycosylation. |
| T5 | 550-645 | Sentence | denotes | Their presence in the Fc domain has been linked to increased serum clearance of IgG antibodies. |
| T6 | 646-821 | Sentence | denotes | High-performance anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD) is an effective tool for determining glycans present in glycoprotein therapeutics. |
| T7 | 822-895 | Sentence | denotes | We report an improved HPAE-PAD method for IgG oligosaccharide separation. |
| T8 | 896-1011 | Sentence | denotes | The neutral glycans are well resolved, including separation of high-mannose species from typical human IgG glycans. |
| T9 | 1012-1184 | Sentence | denotes | Oligosaccharide identification was performed by comparison to known standards in conjunction with selective exoglycosidase digestion of both standards and released glycans. |
| T10 | 1185-1358 | Sentence | denotes | Retention times of known glycans were compared to the retention times of maltose, maltotriose, and maltotetraose standards to define a retention index value for each glycan. |
| T11 | 1359-1494 | Sentence | denotes | These retention indices were used to aid identification of glycans from an example monoclonal antibody sample of unknown glycosylation. |
| T12 | 1495-1590 | Sentence | denotes | Method ruggedness was evaluated across duplicate systems, analysts, and triplicate column lots. |
| T13 | 1591-1769 | Sentence | denotes | Comparing two systems with different analysts and columns, retention time precision RSDs were between 0.63 and 4.0% while retention indices precision RSDs ranged from 0.27-0.56%. |
| T14 | 1770-1877 | Sentence | denotes | The separation is orthogonal to capillary electrophoresis based separation of labeled IgG oligosaccharides. |
GlyCosmos15-FMA
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 611-616 | Body_part | denotes | serum | FMA:63083 |
| T2 | 1802-1811 | Body_part | denotes | capillary | FMA:63194 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 520-525 | OrganismTaxon | denotes | human | 9606 |
| T2 | 993-998 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 1802-1811 | Body_part | denotes | capillary | http://purl.obolibrary.org/obo/UBERON_0001982 |